Treatments & Techniques
PET — one of the most important tools in clinicians’ armamentarium for cancer diagnosis, staging and therapy evaluation — has a significant limitation: It can scan only a portion of the body at a time. That may change soon, with wide implications for research and clinical practice.
Phillip Gilson, MD: Exploring Safe, Effective Solutions for Male Urinary Incontinence and Erectile Dysfunction
Phillip Gilson, MD, urologic surgeon and erectile dysfunction expert with St. Vincent Medical Group, has two decades of experience helping patients solve frustrating problems. His high-volume practice and history of success make him an expert in finding the right option for each patient’s circumstances.
As liquid biopsies inch closer to becoming a standard of care, questions about their efficacy, use and role in cancer diagnosis and treatment abound. Discordant research findings between liquid and tissue biopsies only add to the confusion.
A new transition model benefits teenagers and young adults with Type 1 diabetes who are moving from pediatric to adult care, researchers say.
When women who are at high risk for breast cancer and have undergone mammography get a letter describing options for further imaging with contrast-enhanced MRI of the breast, they are more apt to return for follow-up screening,...
A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.
Results of a phase 1b clinical trial published in Nature reveal scientists may be one step closer to finding a treatment that safely impedes the biological progression of Alzheimer’s disease.
Rated one of the nation’s top physicians for patient satisfaction in 2015, Gregory Lowe, MD, urologic surgeon and sexual medicine specialist at OhioHealth Urology Physicians, merges high-level expertise with state-of-the-art devices and techniques to treat erectile dysfunction (ED) and male urinary incontinence (UI).
A 2012 initiative that Cherokee Nation Health Services (CNHS) in Oklahoma launched to enhance hepatitis C management has yielded significant, positive results among the American Indian population.
- 1 of 21
- next ›